ADAMTS1 and prostate carcinoma: Furthermore, decreased expression of ADAMTS1 was found in tumor tissue from prostate cancer patients compared to benign prostate tissue, and low levels of ADAMTS1 were associated with increased MVD and metastasis in androgen-independent tumors [19].